Drug Profile


Alternative Names: IZN6N4

Latest Information Update: 13 Oct 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Izun Pharma
  • Class Anti-inflammatories; Herbal medicines
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Stomatitis

Most Recent Events

  • 11 Oct 2017 Positive efficacy data from a phase II trial in Stomatitis released by Izun Pharma
  • 11 Oct 2017 Izun Pharma completes a phase II trial in Stomatitis (Prevention) in USA and Israel (NCT01400620)
  • 22 Feb 2016 IZN 6N4 is still in phase II trials for Stomatitis (Prevention) in Israel and USA (Buccal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top